Genetic polymorphisms of myeloperoxidase and their effect on hypertension

References

• Tsimikas S. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol. 2008;101:34D–42D.
   PubMed Web of Science ®Google Scholar
• Strobel NA, Fassett RG, Marsh SA, Coombes JS. Oxidative stress biomarkers as predictors of cardiovascular disease. Int. J Cardiol. 2011;147:191–201.
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Oxidative stress: New approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol. 2003;91:12A–16A.
   PubMed Web of Science ®Google Scholar
• Podrez EA, bu-Soud HM, Hazen SL. Myeloperoxidase- generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28:1717–1725.
   PubMed Web of Science ®Google Scholar
• Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone–retinoic acid response element. J Biol Chem. 1996;271:14412–14420.
   PubMed Web of Science ®Google Scholar
• Doi K, Noiri E, Maeda R, Nakao A, Kobayashi S, Tokunaga K, et al. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients. Hypertens Res. 2007;30:1193–1198.
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286: 2136–2142.
   PubMed Web of Science ®Google Scholar
• Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J. 2001;142:336–339.
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff CM, et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl. 2003;S172–S176.
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Department of Health, Taiwan Government. 2010; http://www.doh.gov.tw/CHT2006/other/ShowCopy.aspx?doc_no = 32&class_no = 25
   Google Scholar
• London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 1997; 57:5001–5003.
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452–456.
   PubMed Web of Science ®Google Scholar
• Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens. 2007;20:370–377.
   PubMed Web of Science ®Google Scholar
• Bog-Hansen E, Lindblad U, Ranstam J, Melander A, Rastam L. Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project. Diabetes Obes Metab. 2001;3:25–31.
   PubMedGoogle Scholar
• Fujita T. Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol Dial Transplant. 2007; 22:3102–3107.
   PubMed Web of Science ®Google Scholar
• Simons LA, Simons J, Jones AS. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community. Aust NZ J Med 1984;14:215–221.
   PubMedGoogle Scholar
• Okubo Y, Suwazono Y, Kobayashi E, Nogawa K. An association between smoking habits and blood pressure in normotensive Japanese men: A 5-year follow-up study. Drug Alcohol Depend. 2004;73:167–174.
   PubMed Web of Science ®Google Scholar
• Cagirci G, Cay S, Karakurt O, Eryasar N, Kaya V, Canga A, et al. Influence of heavy cigarette smoking on heart rate variability and heart rate turbulence parameters. Ann Noninvasive Electrocardiol. 2009;14:327–332.
   PubMedGoogle Scholar
• Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93:621–635.
   PubMed Web of Science ®Google Scholar
• Nauseef WM. Insights into myeloperoxidase biosynthesis from its inherited deficiency. J Mol Med 1998;76:661–668.
   PubMed Web of Science ®Google Scholar
• Weiss SJ, Test ST, Eckmann CM, Roos D, Regiani S. Brominating oxidants generated by human eosinophils. Science 1986;234:200–203.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase: Contribution to the microbicidal activity of intact leukocytes. Science 1970;169: 1095–1097.
   PubMed Web of Science ®Google Scholar
• Maki RA, Tyurin VA, Lyon RC, Hamilton RL, DeKosky ST, Kagan VE, et al. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem. 2009;284:3158–3169.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W, Zhang Y, Zhao X, Yang D. Clinical significance of a myeloperoxidase gene polymorphism and inducible nitric oxide synthase expression in cirrhotic patients with hepatopulmonary syndrome. J Huazhong Univ Sci Technol Med Sci. 2010;30:437–442.
   PubMedGoogle Scholar
• Kumar AP, Piedrafita FJ, Reynolds WF. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen- dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem. 2004;279:8300–8315.
   PubMed Web of Science ®Google Scholar
• Ergen A, Isbir S, Timirci O, Tekeli A, Isbir T. Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep. 2011;38:887–891.
   PubMed Web of Science ®Google Scholar
• Pope SK, Kritchevsky SB, Ambrosone C, Yaffe K, Tylavsky F, Simonsick EM, et al. Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study. Am J Epidemiol. 2006;163: 1084–1090.
   PubMed Web of Science ®Google Scholar
• Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, et al. Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007;9:67–73.
   PubMed Web of Science ®Google Scholar
• Hoy A, Leininger-Muller B, Poirier O, Siest G, Gautier M, Elbaz A, et al. Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis. 2003;167:223–230.
   PubMedGoogle Scholar
• Arslan S, Pinarbasi H, Silig Y. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population. Mol Med Rep. 2011;4:87–92.
   PubMed Web of Science ®Google Scholar
• Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med. 2004;116:429–430.
   PubMed Web of Science ®Google Scholar
• Zhong C, Quanzhong Y, Genshan M, Hua Z, Ruolong Z, Jiahong W, et al. Myeloperoxidase gene-463G – A polymorphism and premature coronary artery disease. Genet Mol Biol. 2009;32:260–263.
   PubMedGoogle Scholar
• Makela R, Loimaala A, Nenonen A, Mercuri M, Vuori I, Huhtala H, et al. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. Clin Biochem. 2008;41: 532–537.
   PubMed Web of Science ®Google Scholar
• Colombani AL, Carneiro L, Benani A, Galinier A, Jaillard T, Duparc T, et al. Enhanced hypothalamic glucose sensing in obesity: Alteration of redox signaling. Diabetes. 2009; 58:2189–2197.
   PubMedGoogle Scholar
• Mellor K, Ritchie RH, Meredith G, Woodman OL, Morris MJ, Delbridge LM. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy. Nutrition. 2010;26:842–848.
   PubMedGoogle Scholar